Eastern Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PR
AAS
EWM
LHWM
MWA
PI
SWM
MAM
YIH
Eastern Bank's XBI Position: Q2 2026 in Review
Eastern Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 228 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #668.
Eastern Bank first reported a position in XBI in Q4 2018 and has held it in 25 quarters since. The position peaked at $30.5M in Q4 2020. 119 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Eastern Bank held 228 shares of State Street SPDR S&P Biotech ETF worth $36.1K as of Q2 2026.
- Eastern Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #668 holding.
- Eastern Bank first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 25 quarters since.
- Eastern Bank's State Street SPDR S&P Biotech ETF position peaked at $30.5M in Q4 2020.
- 119 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.